Glucagon-like peptide-1 (GLP-1)-based agents (including GLP-1 analogues and dipeptidyl peptidase 4 inhibitors) have been recently approved as new therapeutic options for patients with type 2 diabetes, based upon the evidence that GLP-1 can stimulate glucose-dependent insulin secretion from pancreatic cells
This fat is not distributed in the same manner as typical weight gain
There are also a few important precautions to keep in mind
These medications work while being used, with weight regain common after stopping
We'd have people over and everybody would be having their social drinks, a beer, a glass of wine, and I had zero desire
Finally, increased mTOR activity is shown to attenuate autophagy (74) which, in the intestine, is an important process to limit chronic intestinal inflammation (75)